Patents by Inventor Lawrence Patrick Carter

Lawrence Patrick Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240189270
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Application
    Filed: February 20, 2024
    Publication date: June 13, 2024
    Inventors: Lawrence Patrick CARTER, Yuan Lu, Katayoun Zomorodi
  • Publication number: 20240180866
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Application
    Filed: December 8, 2023
    Publication date: June 6, 2024
    Inventors: Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
  • Publication number: 20240033243
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Application
    Filed: May 12, 2023
    Publication date: February 1, 2024
    Inventors: Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
  • Publication number: 20240018098
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
    Type: Application
    Filed: September 18, 2023
    Publication date: January 18, 2024
    Inventors: Fionn Hurley, Lawrence Patrick Carter
  • Patent number: 11865098
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Grant
    Filed: May 12, 2023
    Date of Patent: January 9, 2024
    Assignee: Axsome Malta Ltd.
    Inventors: Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
  • Patent number: 11780805
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: October 10, 2023
    Assignee: Axsome Malta Ltd.
    Inventors: Fionn Hurley, Lawrence Patrick Carter
  • Patent number: 11648232
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: May 16, 2023
    Assignee: Axsome Malta Ltd.
    Inventors: Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
  • Publication number: 20220098145
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
    Type: Application
    Filed: September 9, 2021
    Publication date: March 31, 2022
    Inventors: Fionn Hurley, Lawrence Patrick Carter
  • Patent number: 11149000
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: October 19, 2021
    Assignee: Jazz Pharmaceuticals Ireland Limited
    Inventors: Fionn Hurley, Lawrence Patrick Carter
  • Publication number: 20210205257
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Application
    Filed: March 25, 2021
    Publication date: July 8, 2021
    Inventors: Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
  • Patent number: 10959976
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: March 30, 2021
    Assignee: Jazz Pharmaceuticals Ireland Limited
    Inventors: Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
  • Patent number: 10912754
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: February 9, 2021
    Assignee: Jazz Pharmaceuticals Ireland Limited
    Inventors: Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
  • Publication number: 20200290955
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
    Type: Application
    Filed: June 3, 2020
    Publication date: September 17, 2020
    Inventors: Fionn Hurley, Lawrence Patrick Carter
  • Publication number: 20200281886
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Application
    Filed: May 19, 2020
    Publication date: September 10, 2020
    Inventors: Lawrence Patrick Carter, Yuan Lu
  • Patent number: 10710958
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: July 14, 2020
    Assignee: Jazz Pharmaceuticals Ireland Limited
    Inventors: Fionn Hurley, Lawrence Patrick Carter
  • Publication number: 20200163927
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that “normal” levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
    Type: Application
    Filed: June 1, 2018
    Publication date: May 28, 2020
    Inventors: Lawrence Patrick Carter, Yuan Lu
  • Publication number: 20190218175
    Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
    Type: Application
    Filed: October 6, 2017
    Publication date: July 18, 2019
    Inventors: Fionn Hurley, Lawrence Patrick Carter